Microwave-assisted synthesis of 5-aminopyrazol-4-yl ketones and the p38MAPK inhibitor RO3201195 for study in Werner syndrome cells

被引:28
作者
Bagley, Mark C. [1 ]
Davis, Terence [2 ]
Dix, Matthew C. [1 ]
Murziani, Paola G. S. [1 ]
Rokicki, Michal J. [2 ]
Kipling, David [2 ]
机构
[1] Cardiff Univ, Sch Chem, Cardiff CF10 3AT, S Glam, Wales
[2] Cardiff Univ, Sch Chem, Dept Pathol, Cardiff CF14 4XN, S Glam, Wales
基金
英国生物技术与生命科学研究理事会; 英国医学研究理事会;
关键词
p38; MAPK; Werner syndrome; RO3201195; microwaves; heterocycles;
D O I
10.1016/j.bmcl.2008.05.037
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
5-Aminopyrazol-4-yl ketones are prepared rapidly and efficiently using microwave dielectric heating from beta-ketonitriles by treatment with N, N'-diphenylformamidine followed by heterocyclocondensation by irradiation with a hydrazine. The inhibitory activity of RO3201195 prepared by this methodology was confirmed in hTERT-immortalized HCA2 and WS dermal fibroblasts at 200 nM concentration, both by ELISA and immunoblot assay, and displays excellent kinase selectivity for p38 alpha MAPK over the related stress-activated kinase JNK. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3745 / 3748
页数:4
相关论文
共 20 条
[1]   Rapid synthesis of VX-745: p38 MAP kinase inhibition in Werner syndrome cells [J].
Bagley, Mark C. ;
Davis, Terence ;
Dix, Matthew C. ;
Rokicki, Michal J. ;
Kipling, David .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (18) :5107-5110
[2]   Regioselective microwave-assisted synthesis of substituted pyrazoles from ethynyl ketones [J].
Bagley, Mark C. ;
Lubinu, M. Caterina ;
Mason, Christopher .
SYNLETT, 2007, (05) :704-708
[3]   Microwave-assisted synthesis of N-pyrazole ureas and the p38α inhibitor BIRB 796 for study into accelerated cell ageing [J].
Bagley, Mark C. ;
Davis, Terence ;
Dix, Matthew C. ;
Widdowson, Caroline S. ;
Kipling, David .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2006, 4 (22) :4158-4164
[4]   Replicative senescence: An old lives' tale? [J].
Campisi, J .
CELL, 1996, 84 (04) :497-500
[5]   Prevention of accelerated cell aging in Werner syndrome using a p38 mitogen-activated protein kinase inhibitor [J].
Davis, T ;
Baird, DM ;
Haughton, MF ;
Jones, CJ ;
Kipling, D .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2005, 60 (11) :1386-1393
[6]   Synthesis and in vivo activity of MK2 and MK2 substrate-selective p38αMAPK inhibitors in Werner syndrome cells [J].
Davis, Terence ;
Bagley, Mark C. ;
Dix, Matthew C. ;
Murziani, Paola G. S. ;
Rokicki, Michal J. ;
Widdowson, Caroline S. ;
Zayed, Jameel M. ;
Bachler, Marcus A. ;
Kipling, David .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (24) :6832-6835
[7]   The role of cellular senescence in Werner syndrome - Toward therapeutic intervention in human premature aging [J].
Davis, Terence ;
Wyllie, Fiona S. ;
Rokicki, Michal J. ;
Bagley, Mark C. ;
Kipling, David .
BIOGERONTOLOGY: MECHANISMS AND INTERVENTIONS, 2007, 1100 :455-469
[8]   Prevention of Accelerated Cell Aging in the Werner Syndrome [J].
Davis, Terence ;
Haughton, Michele F. ;
Jones, Christopher J. ;
Kipling, David .
UNDERSTANDING AND MODULATING AGING, 2006, 1067 :243-247
[9]   Werner syndrome as an example of inflamm-aging: Possible therapeutic opportunities for a progeroid syndrome? [J].
Davis, Terence ;
Kipling, David .
REJUVENATION RESEARCH, 2006, 9 (03) :402-407
[10]   The preparation of benzoylacetic ester and some of its homologs [J].
Dorsch, JB ;
McElvain, SM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1932, 54 :2960-2964